Labiotech.eu

News and Trends 13 Jun 2022

New EY report outlines challenges for biotech

Although the biotech industry performed strongly during the COVID-19 pandemic, it now faces challenges to valuations and access to capital. This is according to the 32nd edition of the Beyond Borders report produced by Ernst & Young LLP (EY US). The report, which EY said is a ‘moment-in-time’ snapshot of the industry, says despite the […]

June 13, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 13 Jun 2022

GSK positive on RSV vaccine for older adults

GSK plc has announced positive headline results from its AReSVi 006 phase III trial. AReSVi 006 is a phase III trial investigating GSK’s respiratory syncytial virus (RSV) vaccine candidate for adults aged 60 years and above. GSK said no unexpected safety concerns were observed. Dr Hal Barron, chief scientific officer and president, R&D, GSK, said, […]

June 13, 2022 - 3 minutesmins - By Jim Cornall

In Depth 13 Jun 2022

DNA synthesis: tackling the main bottleneck in biology research

A wave of new technologies to synthesize DNA faster, more cheaply and more accurately could have a far-reaching impact across all areas of biology research. More than ten years ago, Sylvain Gariel was working for the French oil company TotalEnergies, engineering microorganisms to produce biofuels. It was tedious work. “You had to introduce hundreds of […]

June 13, 2022 - 10 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Jun 2022

Expansion into Europe for BlueRock Therapeutics

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has established a new site for cell therapy innovation on Bayer’s campus in Berlin, Germany. The move comes as part of the company’s growth strategy. A multidisciplinary BlueRock team will be set up during 2022 to provide clinical development and operational […]

June 10, 2022 - 2 minutesmins - By Jim Cornall

Inside Labiotech 10 Jun 2022

Beyond Biotech – the new Labiotech podcast

Labiotech.eu has just gone global with its coverage, and now we are gearing up for the first Labiotech.eu podcast. According to Spotify, in 2021 there were 1.2 million podcasts launched. So does the world need another one? We’d like to think the answer is yes! We are trying to ensure our new podcast, Beyond Biotech, […]

June 10, 2022

News and Trends 9 Jun 2022

Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods

Belgian biopharma firm Ziphius Vaccines is set to collaborate with the University of Antwerp to research and develop a lipid library for optimized delivery systems of self-amplifying RNA-based drugs (saRNA) and therapeutics. Messenger RNA (mRNA) vaccines deliver genetic instructions to cells to create proteins that then train the immune system against a pathogen, such as […]

June 9, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 9 Jun 2022

Amaroq Therapeutics ‘hits early milestones’ in cancer treatment

New Zealand biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a promising initial development phase. The company, a start-up spun out of the University of Otago, is focused on developing a new class of therapeutics that target long non-coding RNAs (lncRNA) in cancer. Sarah Diermeier, chief scientific officer and founder of […]

June 9, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 9 Jun 2022

New Forbion life sciences fund hits €470M

European life sciences venture capital firm Forbion, has announced the first €470M ($500M) close of its Forbion Growth Opportunities Fund II. The fund will focus on investing in late-stage European life sciences companies. The new fund has attracted several new institutional investors, including pension funds PME and PMT, the Ewing Marion Kauffman Foundation and Reggeborgh, […]

June 9, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 9 Jun 2022

Cocuus raises funds to upscale alt-protein 3D bioprinting technology

Spanish start-up Cocuus has raised €2.5M ($2.7M) in its pre-Series A funding round. The funds will be used to scale up its 3D bioprinting process for producing plant or cell-based animal protein food analogs. The company recently completed the Eatable Adventures acceleration program, one of the top three global accelerators for foodtech start-ups. Eatable Adventures […]

June 9, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 8 Jun 2022

Neuroendocrine cancer under the spotlight as Ariceum Therapeutics launches

Ariceum Therapeutics, a private biotech company developing a radiopharmaceutical product for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat cancers, has completed an oversubscribed €25M ($26.7M) Series A financing round. Ariceum was co-founded by EQT Life Sciences (formerly LSP) and HealthCap, which also co-led the financing that was joined by Pureos Bioventures. Ipsen […]

June 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Jun 2022

The top European biotech investments in May 2022

Biotech investments in Europe jumped in May 2022 with a large initial public offering from the US/UK firm PepGen. Meanwhile, oncology companies Tubulis, Domain Therapeutics, and EngImmune Therapeutics topped the private biotech investment rounds. Public stock markets remain in a volatile state for biotech companies, with a lot of uncertainty remaining over widespread inflation. Against […]

June 8, 2022 - 4 minutesmins - By Jonathan Smith

covid 19 vaccines adenovirus adenoviral vector

News and Trends 8 Jun 2022

New COVID antibody cocktail developed

French biotech contract research organization ProteoGenix, Aseem Healthcare, and life sciences consultancy agency Trident Biopharm Solutions have combined on a new antibody cocktail effective against major variants of SARS-CoV-2. The cocktail of four human neutralizing antibodies (AH-5-COV) was generated by screening the plasma of a COVID-19 survivor using ProteoGenix’s phage display platform. The new treatment […]

June 8, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

New EY report outlines challenges for biotech

GSK positive on RSV vaccine for older adults

DNA synthesis: tackling the main bottleneck in biology research

Expansion into Europe for BlueRock Therapeutics

Beyond Biotech – the new Labiotech podcast

Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods

Amaroq Therapeutics ‘hits early milestones’ in cancer treatment

New Forbion life sciences fund hits €470M

Cocuus raises funds to upscale alt-protein 3D bioprinting technology

Neuroendocrine cancer under the spotlight as Ariceum Therapeutics launches

The top European biotech investments in May 2022

New COVID antibody cocktail developed

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!